Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT06547398

Prostate Adaptive Radiation Therapy

Led by Royal North Shore Hospital · Updated on 2026-02-05

130

Participants Needed

1

Research Sites

317 weeks

Total Duration

On this page

Sponsors

R

Royal North Shore Hospital

Lead Sponsor

N

Northern Sydney and Central Coast Area Health Service

Collaborating Sponsor

AI-Summary

What this Trial Is About

Prostate ART is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for prostate cancer patients. Adaptive radiotherapy is a new technology that provides the ability to account for daily changes in anatomy. Adaptive radiotherapy also provides a foundation for which radiotherapy margins might be safely reduced. Phase 1 of this study is looking to see if a radiation therapist centred adaptive workflow can be implemented. If phase 1 of this study is safe and feasible, the study will proceed to phase 2. Part 2 of the study looks at using adaptive technology to reduce radiation treatment margins. The primary aim of this study is to see whether margin reduced treatment using adaptive radiotherapy can reduce side effects for prostate cancer patients.

CONDITIONS

Official Title

Prostate Adaptive Radiation Therapy

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age > 18
  • Biopsy proven prostate malignancy
  • Definitive treatment is radiotherapy to the prostate alone
  • ECOG performance status 0-2
  • Ability to understand and the willingness to sign an informed consent
Not Eligible

You will not qualify if you...

  • Presence of hip prosthesis
  • Patient separation from prostate centre to skin edge > 24cm, measured on diagnostic scan

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Northern Sydney Cancer Centre, Royal North Shore Hospital

St Leonards, New South Wales, Australia, 2065

Actively Recruiting

Loading map...

Research Team

N

Nada Cheikh-Ali

CONTACT

H

Heidi Tsang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here